These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1381762)

  • 21. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
    Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
    Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function].
    Vogler AC; Silber S; Vogel M; Theisen K
    Z Kardiol; 1989; 78 Suppl 2():183-7; discussion 188-9. PubMed ID: 2588761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effects of verapamil, captopril and their combination at rest and during dynamic exercise.
    Di Somma S; Petitto M; Liguori V; Carotenuto A; Paulucci A; De Divitiis O
    Arzneimittelforschung; 1992 Feb; 42(2):103-7. PubMed ID: 1610414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene.
    Mateus FH; Lepera JS; Marques MP; Boralli VB; Lanchote VL
    Can J Physiol Pharmacol; 2008 May; 86(5):232-9. PubMed ID: 18432283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
    Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
    J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers.
    Fleishaker JC; Sisson TA; Carel BJ; Azie NE
    Clin Pharmacol Ther; 2000 May; 67(5):498-503. PubMed ID: 10824628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration.
    Abernethy DR; Wainer IW; Longstreth JA; Andrawis NS
    J Pharmacol Exp Ther; 1993 Aug; 266(2):904-11. PubMed ID: 8355215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Do changes in dietary salt influence blood pressure of hypertensive patients pharmacologically controlled with verapamil? The Salt-Switching-Study (SSS).
    Redón J; Lozano JV; de la Figuera M; Rodriguez JC; Garrido J; Alés-Martínez JE; Alvarez-Cantalapiedra I; Velasco-Quintana J
    J Hum Hypertens; 1995 Feb; 9(2):143-7. PubMed ID: 7752177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sustained release verapamil in essential hypertension].
    Yodfat Y; Nusbaum M; Gibor Y
    Harefuah; 1991 May; 120(10):581-4. PubMed ID: 1937192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparisons of verapamil administration twice and three times daily in hypertension.
    Salmela PI; Gordin A; Salo H; Ottoila P; Jounela AJ
    Ann Clin Res; 1988; 20(3):195-200. PubMed ID: 3058014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Favourable interaction of calcium antagonist plus ACE inhibitor on cardiac haemodynamics in treating hypertension: rest and effort evaluation.
    Di Somma S; Carotenuto A; de Divitiis M; Paulucci A; Galderisi M; Cuocolo A; de Divitiis O
    J Hum Hypertens; 1995 Mar; 9(3):163-8. PubMed ID: 7783096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of verapamil in arterial hypertension].
    Carrasco RM; Luna RL; Rocha MC
    Arq Bras Cardiol; 1979 Mar; 32(3):207-11. PubMed ID: 475607
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of verapamil on the pressure response induced by cycloergometry in hypertensive patients].
    Albanesi FM; Albuquerque DC; Rocha PJ; Benchimol CB; Schlesinger P; Benchimol AB
    Arq Bras Cardiol; 1979 Mar; 32(3):203-5. PubMed ID: 475606
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical use of verapamil in hypertensive crisis].
    Gushi N; Mateos DA; Magaldi JB
    Arq Bras Cardiol; 1976 Feb; 29(1):67-74. PubMed ID: 779727
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action of verapamil in a single oral dose in arterial hypertension. Evaluation by echocardiography and phonomechanocardiography].
    Ortiz J; Barreto AC; Savioli RM; Barbato AJ; Netto MP; Monaco CA; Del Nero Júnior E; Tranchesi J; Pileggi F
    Arq Bras Cardiol; 1979 Jan; 32(1):63-70. PubMed ID: 464849
    [No Abstract]   [Full Text] [Related]  

  • 38. Once a day verapamil in essential hypertension.
    Müller FB; Ha HR; Hotz H; Schmidlin O; Follath F; Bühler FR
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):143S-147S. PubMed ID: 3530298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-hypertensive effect of intravenous verapamil in rats with experimental arterial hypertension].
    Vichi FL; Mazotti L; Capucci de Oliveira AF; Dráusio Martins J; Bernardes J
    Arq Bras Cardiol; 1978 Feb; 31 Suppl 1():31-4. PubMed ID: 678164
    [No Abstract]   [Full Text] [Related]  

  • 40. R-verapamil: pharmacokinetics and effects on PR interval, blood pressure and heart rate.
    Ahmed JH; Godden J; Meredith PA; Elliott HL
    Br J Clin Pharmacol; 1993 Aug; 36(2):93-8. PubMed ID: 8398588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.